Literature DB >> 19429370

Production of Th1- and Th2-dependent cytokines induced by the Chinese medicine herb, Rhodiola algida, on human peripheral blood monocytes.

H X Li1, S C W Sze, Y Tong, T B Ng.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Rhodiola algida, an herb ingredient used in Chinese medicine, has been clinically proven to be effective in enhancing human immune responses.
AIM OF STUDY: This study attempted to identify the potential immunomodulatory effect of Rhodiola algida extract in human immune system in vitro, and to examine its underlying molecular effects.
MATERIALS AND METHODS: Firstly, the bioactive marker compound salidroside was used for standardization of Rhodiola algida extract by reversed-phase HPLC. Secondly, the regulation of human immune responses was investigated in human peripheral blood monocytes. A series of cytokines known to play important roles in the human immune responses were examined.
RESULTS: The current study provided quantitative assay for the marker compound, salidroside, in the Rhodiola algida extract for ensuring the quality consistency of Rhodiola algida used in the following experiments. Biological assay indicated that Rhodiola algida stimulates human peripheral blood lymphocytes and its underlying immunomodulatory effects probably through its regulation of IL-2 in Th1 cells and IL-4, IL-6, IL-10 in Th2 cells.
CONCLUSION: The findings may enable us to further explain the pharmacological properties in Chinese medicine and make Rhodiola algida a very promising immunomodulating agent.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19429370     DOI: 10.1016/j.jep.2009.03.009

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  7 in total

1.  Salidroside improves behavioral and histological outcomes and reduces apoptosis via PI3K/Akt signaling after experimental traumatic brain injury.

Authors:  Szu-Fu Chen; Hsin-Ju Tsai; Tai-Ho Hung; Chien-Cheng Chen; Chao Yu Lee; Chun-Hu Wu; Pei-Yi Wang; Nien-Chieh Liao
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

2.  Rhodiola rosea suppresses thymus T-lymphocyte apoptosis by downregulating tumor necrosis factor-α-induced protein 8-like-2 in septic rats.

Authors:  Ming-Wei Liu; Mei-Xian Su; Wei Zhang; Lin-Ming Zhang; Yun-Hui Wang; Chuan-Yun Qian
Journal:  Int J Mol Med       Date:  2015-06-10       Impact factor: 4.101

3.  Effects of the aqueous extract of a Tibetan herb, Rhodiola algida var. tangutica on proliferation and HIF-1α, HIF-2α expression in MCF-7 cells under hypoxic condition in vitro.

Authors:  Yu-Juan Qi; Sen Cui; Dian-Xiang Lu; Ying-Zhong Yang; Yushuang Luo; Lan Ma; Yan Ma; Tana Wuren; Rong Chang; Lei Qi; Ba-Ji Ben; Jun Han; Ri-Li Ge
Journal:  Cancer Cell Int       Date:  2015-08-15       Impact factor: 5.722

4.  Changes of cytokines during a spaceflight analog--a 45-day head-down bed rest.

Authors:  Xi Xu; Cheng Tan; Pingping Li; Shusong Zhang; Xuewen Pang; Hongju Liu; Li Li; Xiuyuan Sun; Yu Zhang; Hounan Wu; Xiaoping Chen; Qing Ge
Journal:  PLoS One       Date:  2013-10-15       Impact factor: 3.240

5.  Salidroside attenuates concanavalin A-induced hepatitis via modulating cytokines secretion and lymphocyte migration in mice.

Authors:  Baoji Hu; Yun Zou; Shanshan Liu; Jun Wang; Jiali Zhu; Jinbao Li; Lulong Bo; Xiaoming Deng
Journal:  Mediators Inflamm       Date:  2014-04-07       Impact factor: 4.711

Review 6.  A survey of chinese medicinal herbal treatment for chemotherapy-induced oral mucositis.

Authors:  Gesa Meyer-Hamme; Kathrin Beckmann; Janine Radtke; Thomas Efferth; Henry Johannes Greten; Matthias Rostock; Sven Schröder
Journal:  Evid Based Complement Alternat Med       Date:  2013-10-28       Impact factor: 2.629

Review 7.  Medicinal Plants and Phytochemicals for the Treatment of Pulmonary Hypertension.

Authors:  Seyed Vahid Jasemi; Hosna Khazaei; Ina Yosifova Aneva; Mohammad Hosein Farzaei; Javier Echeverría
Journal:  Front Pharmacol       Date:  2020-03-12       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.